SEARCH

SEARCH BY CITATION

References

  • Apted FIC (1970a) Clinical manifestations and diagnosis of sleeping sickness. In: The African Trypanosomiases (ed. MulliganHW) George Allen and Unwin Ltd, London, pp. 661683.
  • Apted FIC (1970b) The epidemiology of Rhodesian Sleeping Sickness. In: The African Trypanosomiasis (ed. MulliganHW) George Allen and Unwin Ltd, London, pp. 645660.
  • Ayed Z, Brindel I, Bouteille B et al. (1997) Detection and characterization of autoantibodies directed against neurofilament proteins in human African trypanosomiasis. American Journal of Tropical Medicine and Hygiene 57, 16.
  • Bisser S, Bouteille B, Sarda J et al. (1997) Apport des examens biochimiques dans le diagnostic de la phase nerveuse de la trypanosomose humaine. Bulletin de la Société de Pathologie Exotique et de ses Filiales 90, 321326.
  • Bisser S, Ayed Z, Bouteille B et al. (2000) Central nervous system involvement in African trypanosomiasis: presence of anti-galactocerebroside antibodies in patients’ cerebrospinal fluid. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 225226.
  • Bisser S, Lejon V, Preux PM et al. (2002) Blood-cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness. Journal of the Neurological Sciences 193, 127135.
  • Boa YF, Traore MA, Doua F et al. (1988) Les différents tableaux cliniques actuels de la trypanosomiase humaine Africaine àT. b. gambiense. Analyse de 300 dossiers du foyer de Daloa, Côte-d'Ivoire. Bulletin de la Société de Pathologie Exotique et de ses Filiales 81, 427444.
  • Broden A & Rodhain J (1908) Le liquide cérébro-spinal dans la trypanosomiase humaine. Bulletin de la Société de Pathologie Exotique et de ses Filiales 1, 496499.
  • Burri C & Brun R (2003) Human African trypanosomiasis. In: Manson's Tropical Diseases 21st edn (eds CookGC & ZumlaAI) Elsevier, Edinburgh, pp. 13031323.
  • Burri C, Nkunku S, Merolle A et al. (2000) Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial. The Lancet 355, 14191425.
  • Büscher P & Lejon V (2004) Diagnosis of human African trypanosomiasis. In: Trypanosomiasis Textbook (eds MaudlinI, HolmesP & MilesMA) CABI Publishing, Oxfordshire, pp. 203218.
  • Büscher P, Lejon V, Magnus E & Van Meirvenne N (1999) Improved latex agglutination test for detection of antibodies in serum and cerebrospinal fluid of Trypanosoma brucei gambiense infected patients. Acta Tropica 73, 1120.
  • Cattand P, Miézan BT & de Raadt P (1988) Human African trypanosomiasis: use of double centrifugation of cerebrospinal fluid to detect trypanosomes. Bulletin of the World Health Organization 66, 8386.
  • Courtioux B, Boda C, Nangouma A et al. (2003) A propos d'un nouveau test pour le diagnostic de terrain de la phase nerveuse de la trypanosomose humaine africaine. Medicine Tropicale 63, 327.
  • Doua F, Miézan TW, Sanon SR, Boa YF & Baltz T (1996) The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis. American Journal of Tropical Medicine and Hygiene 55, 586588.
  • Duggan AJ & Hutchinson MP (1966) Sleeping sickness in europeans: a review of 109 cases. Journal of Tropical Medicine and Hygiene 69, 124131.
  • Dumas M & Bisser S (1999) Clinical aspects of human African trypanosomiasis. In: Progress in Human African Trypanosomiasis, Sleeping Sickness (eds DumasM, BouteilleB & BuguetA) Springer, Paris, pp. 215233.
  • Dumas M & Girard PL (1978) Human African trypanosomiasis (Sleeping sickness). In: Handbook of Clinical Neurology, Vol 35: Infections of the Nervous System. Part III (eds VinkenPJ & BruynGW) North-Holland Publishing Co., Amsterdam, pp. 6783.
  • Edan G (1979) Signes cliniques et biologiques des trypanosomiases àT. gambiense vues au stade d'atteinte méningo-encéphalitique. Médecine Tropicale 39, 499507.
  • Greenwood BM & Whittle HC (1973) Cerebrospinal-fluid IgM in patients with sleeping-sickness. The Lancet 2, 525527.
  • Greenwood BM & Whittle HC (1980) The pathogenesis of sleeping sickness. Transactions of the Royal Society of Tropical Medicine and Hygiene 74, 716725.
  • Greenwood BM, Whittle HC, Oduloju KO & Dourmashkin RR (1976) Lymphocytic infiltration of the brain in sleeping sickness. British Medical Journal 2, 12911292.
  • Jamonneau V, Solano P, Garcia A et al. (2003) Stage determination and therapeutic decision in human African trypanosomiasis: value of PCR and IgM quantification on the cerebrospinal fluid of sleeping sickness patients in Côte d'Ivoire. Tropical Medicine and International Health 8, 589594.
  • Jauberteau M-O, Bisser S, Ayed Z et al. (1994) Détection d'autoanticorps anti-galactocérébrosides au cours de la trypanosomose humaine africaine. Bulletin de la Société de Pathologie Exotique et de ses Filiales 87, 333336.
  • Kennedy PGE (2004) Human African trypanosomiasis of the CNS: current issues and challenges. Journal of Clinical Investigation 113, 496504.
  • Kirchhoff LV (1998) Use of a PCR assay for diagnosing African trypanosomiasis of the CNS: a case report. Central African Journal of Medicine 44, 134136.
  • Knobloch J, Tischendorf F, König J & Mehlitz D (1984) Evaluation of immunoassays for diagnosis and management of sleeping sickness in Liberia. Tropenmedizin und Parasitologie 35, 137140.
  • Kristensson K & Bentivoglio M (1999) Pathology of African trypanosomiasis. In: Progress in Human African Trypanosomiasis, Sleeping Sickness (eds DumasM, BouteilleB & BuguetA) Springer, Paris, pp. 157181.
  • Kyambadde JW, Enyaru JCK, Matovu E, Odiit M & Carasco JF (2000) Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction. Bulletin of the World Health Organization 78, 119124.
  • Lambert PH, Berney M & Kazyumba G (1981) Immune complexes in serum and in cerebrospinal fluid in African trypanosomiasis. Correlation with polyclonal B cell activation and with intracerebral immunoglobulin synthesis. Journal of Clinical Investigation 67, 7785.
  • Laveran A & Mesnil F (1912) Trypanosomiase humaine ou maladie du sommeil. In: Trypanosomes et Trypanosomiases, 2nd edn, Masson et Cie, Paris, pp. 673795.
  • Legros D, Erphas O, Priotto G et al. (2001). Pentamidine versus Mélarsoprol dans le traitement des stades neurologiques précoces de trypanosomiase àT.b. gambiense en Ouganda. Marseille, France. Journées du Pharo, 6–8 septembre 2001.
  • Legros D, Ollivier G, Gastellu-Etchegorry M et al. (2002) Treatment of human African trypanosomiasis – present situation and needs for research and development. Lancet Infectious Diseases 2, 437440.
  • Lejon V, Büscher P, Magnus E et al. (1998) A semi-quantitative ELISA for detection of Trypanosoma brucei gambiense specific antibodies in serum and cerebrospinal fluid of sleeping sickness patients. Acta Tropica 69, 151164.
  • Lejon V, Rosengren LE, Büscher P, Karlsson JE & Sema NH (1999) Detection of light subunit neurofilament and glial fibrillary acidic protein in cerebrospinal fluid of Trypanosoma brucei gambiense-infected patients. American Journal of Tropical Medicine and Hygiene 60, 9498.
  • Lejon V, Lardon J, Kenis G et al. (2002a) Interleukin-6, IL-8 and IL-10 in serum and CSF of T.b. gambiense sleeping sickness patients before and after treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 96, 329333.
  • Lejon V, Legros D, Richer M et al. (2002b) IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test. Tropical Medicine and International Health 7, 685692.
  • Lejon V, Reiber H, Legros D et al. (2003a) Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis. Journal of Infectious Diseases 187, 14751483.
  • Lejon V, Sindic C, Van Antwerpen M-P et al. (2003b) Human African trypanosomiasis: quantitative and qualitative assessment of intrathecal immune response. European Journal of Neurology 10, 711719.
  • Lejon V, Legros D, Savignoni A et al. (2003c) Neuro-inflammatory risk factors for treatment failure in “early second stage” sleeping sickness patients treated with Pentamidine. Journal of Neuroimmunology 144, 132138.
  • Lemesre JL, Noireau F, Makoundou ML, Louembet MT & Frézil J-L (1988) Apport des techniques sérologiques dans l'analyse du liquide céphalo-rachidien de patients congolais atteints de la maladie du sommeil. Bulletin de la Société de Pathologie Exotique et de ses Filiales 81, 506510.
  • Lourie EM (1942) Treatment of sleeping sickness in Sierra Leone. Tropical Medicine and Parasitology 36, 113131.
  • Lucasse C (1964) Fluorescent antibody test as applied to cerebrospinal fluid in human sleeping sickness. Bulletin de la Société de Pathologie Exotique et de ses Filiales 57, 283292.
  • Lumsden WHR, Kimber CD, Evans DA & Doig SJ (1979) Trypanosoma brucei: miniature anion-exchange centrifugation technique for detection of low parasitaemias: adaptation for field use. Transactions of the Royal Society of Tropical Medicine and Hygiene 73, 312317.
  • MacLean L, Odiit M & Sternberg JM (2001) Nitric oxide and cytokine synthesis in human African trypanosomiasis. Journal of Infectious Diseases 184, 10861090.
  • Magnus E, Vervoort T & Van Meirvenne N (1978) A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T.b.gambiense trypanosomiasis. Annales de la Société Belge de Médecine Tropicale 58, 169176.
  • Mattern P (1967) Etude du taux de gamma-globuline dans le liquide cephalo-rachidien. Septième Conférence technique O.C.C.G.E., Mars 1967, 10531056.
  • Mattern P (1968) Etat actuel et résultats des techniques immunologiques utilisées à l'Institut Pasteur de Dakar pour le diagnostic et l’étude de la trypanosomiase humaine africaine. Bulletin of the World Health Organization 38, 18.
  • Mattern P, Pillot J & Bonnardot R (1965) Contribution à l‘étude des immuno-globulines du liquide céphalo-rachidien responsables du phénomène d'immuno-fluorescence dans la neuro-syphilis et dans la trypanosomiase nerveuse. Médecine d'Afrique Noire 6, 219221.
  • Miézan TW, Meda HA, Doua F, Yapo FB & Baltz T (1998) Assessment of central nervous system involvement in gambiense trypanosomiasis: value of the cerebrospinal white cell count. Tropical Medicine and International Health 3, 571575.
  • Miézan TW, Meda AH, Doua F et al. (2000) Single centrifugation of cerebrospinal fluid in a sealed pasteur pipette for simple, rapid and sensitive detection of trypanosomes. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 293.
  • Miézan TW, Djé NN, Doua F & Boa F (2002) Trypanosomose humaine africaine en Côte d'Ivoire: caractéristiques biologiques après traitement. A propos de 812 cas traités dans le foyer de Daloa (Côte d'Ivoire). Bulletin de la Société de Pathologie Exotique et de ses Filiales 95, 362365.
  • Moore A & Richer M (2001) Re-emergence of epidemic sleeping sickness in southern Sudan. Tropical Medicine and International Health 6, 342347.
  • Mott FW (1906) Histological observations on sleeping sickness and other trypanosome infections. Report of the Sleeping Sickness Commission of the Royal Society 7, 345.
  • Nantulya VM (1988) Immunodiagnosis of rhodesiense sleeping sickness: detection of circulating trypanosomal antigens in sera and cerebrospinal fluid by enzyme immunoassay using a monoclonal antibody. Bulletin de la Société de Pathologie Exotique et de ses Filiales 81, 511512.
  • Nantulya VM, Doua F & Molisho D (1992) Diagnosis of Trypanosoma brucei gambiense sleeping sickness using an antigen detection enzyme-linked immunosorbent assay. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 4245.
  • Papadopoulos MC, Abel PM, Agranoff D et al. (2004) A novel and accurate diagnostic test for human African trypanosomiasis. The Lancet 363, 13581363.
  • Pentreath VW, Rees K, Owolabi OA, Philip KA & Doua F (1990) The somnogenic T lymphocyte suppressor prostaglandin D2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients. Transactions of the Royal Society of Tropical Medicine and Hygiene 84, 795799.
  • Pentreath VW, Owolabi AO & Doua F (1992) Survival of Trypanosoma brucei brucei in cerebrospinal fluid. Annals of Tropical Medicine and Parasitology 86, 2934.
  • Pentreath VW, Alafiatayo RA, Crawley B, Doua F & Oppenheim BA (1995) Endotoxins in the blood and cerebrospinal fluid of patients with African sleeping sickness. Parasitology 112, 6773.
  • Pentreath VW, Alafiatayo RA, Barclay GR et al. (1997) Endotoxin antibodies in African sleeping sickness. Parasitology 114, 361365.
  • Pépin J & Milord F (1991) African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis. Transactions of the Royal Society of Tropical Medicine and Hygiene 85, 222224.
  • Pépin J & Milord F (1994) The treatment of human African trypanosomiasis. Advances in Parasitology 33, 249.
  • Pépin J, Milord F, Khonde A et al. (1994) Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 447452.
  • Roffi J, Dedet JP & Garre MT (1979) Diagnostic immunoenzymatique de la trypanosomiase en phase nerveuse par mise en évidence d'anticorps spécifiques dans le liquide céphalorachidien. Médecine et Maladies Infectieuses 9, 306312.
  • Ruiz JA, Simarro PP & Josenando T (2002) Control of human African trypanosomiasis in the Quiçama focus, Angola. Bulletin of the World Health Organization 80, 738745.
  • Schmid C, Nkunku S, Merolle A, Vounatsou P & Burri C (2004) Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness. The Lancet 364, 789790.
  • Scott D (1970) The epidemiology of Gambian Sleeping Sickness. In: The African Trypanosomiasis (ed. MulliganHW) George Allen and Unwin Ltd, London, pp. 614644.
  • Smith DH, Bailey JW & Wellde BT (1989) Immunodiagnostic tests on cerebrospinal fluid in the diagnosis of meningoencephalitic Trypanosoma brucei rhodesiense infection. Annals of Tropical Medicine and Parasitology 83, 9197.
  • Stanghellini A & Josenando T (2001) The situation of sleeping sickness in Angola: a calamity. Tropical Medicine and International Health 6, 330334.
  • Truc P, Jamonneau V, Cuny G & Frézil JL (1999) Use of polymerase chain reaction in human African trypanosomiasis stage determination and follow-up. Bulletin of the World Health Organization 77, 45748.
  • Van Nieuwenhove S, Kande Betu-Ku-Mesu V, Mansinsa Diabakana P, Declercq J & Miaka Mia Bilenge C (2001) Sleeping sickness resurgence in the DRC: the past decade. Tropical Medicine and International Health 6, 335341.
  • Van Meirvenne N (1999) Biological diagnosis of human African trypanosomiasis. In: Progress in Human African Trypanosomiasis, Sleeping Sickness (eds DumasM, BouteilleB & BuguetA) Springer, Paris, pp. 235252.
  • Van Nieuwenhove S (1999) Present strategies in the treatment of human African trypanosomiasis. In: Progress in Human African Trypanosomiasis, Sleeping Sickness (eds DumasM, BouteilleB & BuguetA) Springer, Paris, pp. 253281.
  • Whittle HC, Greenwood BM, Bidwell DE, Bartlett A & Voller A (1977) IgM and antibody measurement in the diagnosis and management of Gambian trypanosomiasis. American Journal of Tropical Medicine and Hygiene 26, 11291135.
  • WHO (1983) Trypanosomiasis Control Manual. African Medical and Research Foundation Nairobi, Kenya, Geneva, pp. 1142.
  • WHO (1998) Control and surveillance of African trypanosomiasis. WHO Technical Report Series 881, 1113.
  • Woo PTK (1971) Evaluation of the haematocrit centrifuge and other techniques for the field diagnosis of human trypanosomiasis and filariasis. Acta Tropica 28, 298303.